This beautiful short film is about life lessons from an 88-year-old woman.
An intimate and artful slice-of-life portrait, Inga captures the routines and reflections of an 88-year-old woman named Inga Boysen.
Read morePsychedelics in Psychiatry
Recently, psychedelic drugs have once again taken popular culture by storm.
From the psychedelic startup companies newly forming on Wall Street to a recent New York Timesarticle that claims "psychedelic drugs are closer to medicinal use," it seems that there is a renewed media and medical interest in acid (LSD), mushrooms (psilocybin), ecstasy (MDMA), ayahuasca, DMT (dimethyltryptamine), and ketamine.
Read morePodcast on Psychedelics
Check out this podcast— Founder and Executive Director of the Multidisciplinary Association for Psychedelic Studies Rick Doblin discusses the role of MDMA-guided psychotherapy in treating PTSD.
Rick shares the story of how he developed a passion for healing the brain with psychedelics and the 35-year journey he’s endured to build a growing non-profit organization. He also explains how to effectively work with drugs that have been aggressively stigmatized and politicized.
Read morePsychedelics and Phantom Limb Pain
An unusual case report illuminates the therapeutic potential of psilocybin and neuroplasticity.
Read morePharmacists and Safe Consumption of Psychedelic Medicines Upon Their FDA Approval
Upon the FDA approval of psychedelic medicine for psychiatric indications—such as MDMA for post-traumatic stress disorder or psilocybin for depression—psychiatric pharmacists in particular and all pharmacists generally, will play a pivotal role in the psychedelic medicine market in the US.
Read moreEcstasy and Psilocybin Are Shaking Up Psychiatry
Researchers are looking at how to safely administer powerful psychedelics for treating depression and post-traumatic stress disorder.
Read moreTest Psilocybin Potency at Home
Want to measure the magic in your mushrooms? The miraculix test kit shows the percentage of psilocybin in your mushrooms.
Read moreMDMA Risks
Gabriel Kearns, M.D. shares important and life-saving harm reduction information in this interview on MDMA.
Read moreIbogaine and 5-MeO-DMT for Traumatic Brain Injuries
Check out this interview with Amber Capone of VETS, on studying ibogaine and 5-MeO-DMT for traumatic brain injuries.
How Mushrooms Started Going Mainstream
In the 1950s, Gordon and Valentina Wasson encountered magic mushrooms. Then they wouldn’t stop talking about them.
Read moreLooking at Psychedelics and Legalization
Michael Pollan looks at the legalization of some psychedelics and asks how should we do drugs now?
Read more